100
Participants
Start Date
June 28, 2018
Primary Completion Date
May 1, 2020
Study Completion Date
May 1, 2020
Enoxaparin
Patients allocated to the experimental arm will receive a parenteral (IA/IV) bolus dose of enoxaparin (0.75 mg/kg) pre PPCI followed by an infusion of 0.75 mg/kg over a 6-hour period to be started as soon as possible when PPCI starts.
Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield
Collaborators (1)
Medical Research Council
OTHER_GOV
Sheffield Teaching Hospitals NHS Foundation Trust
OTHER